10 employees
BioMoti seeks to transform the treatment of cancer by targeted delivery of therapeutics to the intracellular space of cancer cells
2013
$116K
from 1 investors over 1 rounds
BioMoti raised $116K on February 18, 2013
Investors: Oxford Technology Management